ネクセラファーマの株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2022/02/10 | 1,515 | 1,539 | 1,505 | 1,532 | +40 | +2.7% | 1,124,900 |
| 2022/02/09 | 1,479 | 1,500 | 1,455 | 1,492 | +32 | +2.2% | 881,500 |
| 2022/02/08 | 1,470 | 1,493 | 1,449 | 1,460 | -2 | -0.1% | 787,600 |
| 2022/02/07 | 1,498 | 1,520 | 1,456 | 1,462 | -38 | -2.5% | 1,018,600 |
| 2022/02/04 | 1,515 | 1,524 | 1,478 | 1,500 | -23 | -1.5% | 1,207,300 |
| 2022/02/03 | 1,525 | 1,548 | 1,502 | 1,523 | -42 | -2.7% | 1,108,400 |
| 2022/02/02 | 1,528 | 1,575 | 1,528 | 1,565 | +64 | +4.3% | 1,030,800 |
| 2022/02/01 | 1,531 | 1,556 | 1,482 | 1,501 | -16 | -1.1% | 1,645,800 |
| 2022/01/31 | 1,493 | 1,525 | 1,464 | 1,517 | +47 | +3.2% | 1,671,200 |
| 2022/01/28 | 1,510 | 1,529 | 1,437 | 1,470 | -18 | -1.2% | 1,638,600 |
| 2022/01/27 | 1,517 | 1,555 | 1,464 | 1,488 | -30 | -2% | 1,866,400 |
| 2022/01/26 | 1,505 | 1,539 | 1,480 | 1,518 | +17 | +1.1% | 1,338,400 |
| 2022/01/25 | 1,563 | 1,575 | 1,495 | 1,501 | -63 | -4% | 1,572,800 |
| 2022/01/24 | 1,549 | 1,579 | 1,523 | 1,564 | +12 | +0.8% | 1,263,400 |
| 2022/01/21 | 1,580 | 1,585 | 1,507 | 1,552 | -70 | -4.3% | 2,127,000 |
| 2022/01/20 | 1,592 | 1,630 | 1,570 | 1,622 | +34 | +2.1% | 1,531,700 |
| 2022/01/19 | 1,608 | 1,632 | 1,579 | 1,588 | -44 | -2.7% | 1,429,600 |
| 2022/01/18 | 1,654 | 1,680 | 1,618 | 1,632 | -33 | -2% | 1,488,400 |
| 2022/01/17 | 1,700 | 1,700 | 1,653 | 1,665 | -47 | -2.7% | 1,086,400 |
| 2022/01/14 | 1,690 | 1,720 | 1,650 | 1,712 | -15 | -0.9% | 1,504,100 |
| 2022/01/13 | 1,754 | 1,755 | 1,712 | 1,727 | -63 | -3.5% | 1,306,400 |
| 2022/01/12 | 1,801 | 1,804 | 1,761 | 1,790 | +20 | +1.1% | 1,215,500 |
| 2022/01/11 | 1,727 | 1,777 | 1,709 | 1,770 | +46 | +2.7% | 1,840,200 |
| 2022/01/07 | 1,793 | 1,800 | 1,681 | 1,724 | -13 | -0.7% | 4,315,200 |
| 2022/01/06 | 1,805 | 1,846 | 1,730 | 1,737 | -93 | -5.1% | 2,491,200 |
| 2022/01/05 | 1,895 | 1,900 | 1,809 | 1,830 | -96 | -5% | 1,596,500 |
| 2022/01/04 | 1,921 | 1,928 | 1,899 | 1,926 | +22 | +1.2% | 788,600 |
| 2021/12/30 | 1,940 | 1,954 | 1,898 | 1,904 | -37 | -1.9% | 926,900 |
| 2021/12/29 | 1,928 | 1,958 | 1,918 | 1,941 | +13 | +0.7% | 599,000 |
| 2021/12/28 | 1,956 | 1,959 | 1,920 | 1,928 | -21 | -1.1% | 890,100 |
| 2021/12/27 | 1,991 | 1,994 | 1,904 | 1,949 | -64 | -3.2% | 1,719,600 |
| 2021/12/24 | 2,028 | 2,061 | 1,989 | 2,013 | -12 | -0.6% | 1,453,300 |
| 2021/12/23 | 2,013 | 2,059 | 1,977 | 2,025 | -5 | -0.2% | 1,611,600 |
| 2021/12/22 | 1,965 | 2,037 | 1,936 | 2,030 | +62 | +3.2% | 1,679,100 |
| 2021/12/21 | 1,916 | 1,970 | 1,872 | 1,968 | +87 | +4.6% | 2,191,500 |
| 2021/12/20 | 1,847 | 1,941 | 1,823 | 1,881 | +26 | +1.4% | 2,309,900 |
| 2021/12/17 | 1,885 | 1,909 | 1,838 | 1,855 | -12 | -0.6% | 1,636,700 |
| 2021/12/16 | 1,918 | 1,919 | 1,860 | 1,867 | -13 | -0.7% | 1,366,700 |
| 2021/12/15 | 1,888 | 1,891 | 1,838 | 1,880 | -28 | -1.5% | 1,409,900 |
| 2021/12/14 | 1,921 | 1,955 | 1,888 | 1,908 | -7 | -0.4% | 1,315,100 |
| 2021/12/13 | 1,970 | 1,989 | 1,897 | 1,915 | -40 | -2% | 1,749,900 |
| 2021/12/10 | 2,009 | 2,018 | 1,938 | 1,955 | -58 | -2.9% | 1,768,500 |
| 2021/12/09 | 1,998 | 2,062 | 1,985 | 2,013 | -17 | -0.8% | 1,583,900 |
| 2021/12/08 | 2,040 | 2,115 | 2,018 | 2,030 | +22 | +1.1% | 3,241,500 |
| 2021/12/07 | 2,021 | 2,031 | 1,978 | 2,008 | +8 | +0.4% | 1,606,900 |
| 2021/12/06 | 2,051 | 2,054 | 1,965 | 2,000 | -63 | -3.1% | 1,658,300 |
| 2021/12/03 | 2,004 | 2,078 | 1,963 | 2,063 | +73 | +3.7% | 2,710,400 |
| 2021/12/02 | 2,076 | 2,093 | 1,965 | 1,990 | -136 | -6.4% | 3,556,900 |
| 2021/12/01 | 2,148 | 2,173 | 2,020 | 2,126 | +13 | +0.6% | 2,660,900 |
| 2021/11/30 | 2,142 | 2,212 | 2,105 | 2,113 | +3 | +0.1% | 3,753,400 |
651～
700
件表示中 / 4944件
類似銘柄と比較する
現在ご覧いただいている「ネクセラファーマ」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| ネクセラファーマ | 125,100円 | +197.7% | - | 0.00% | 51.12倍 | 1.63倍 |
|
創薬ベンチャー老舗。買収で成長。英国の創薬事業に日本が柱の後期治験・製造販売事業加わる |
| ゼリア新薬 | 233,800円 | +9.6% | +17.5% | 1.97% | 13.21倍 | 1.29倍 |
|
製薬中堅。医療用は消化器系中心。滋養強壮剤「ヘパリーゼ」も柱。スイス企業買収で海外展開 |
| 鳥居薬 | 393,500円 | +11.1% | +20.6% | 3.05% | 23.05倍 | 0.92倍 |
|
ＪＴ傘下。柱の抗ＨＩＶ薬販売権喪失後、自社製品の腎・透析、アレルゲン等の開発強化 |
| 杏林製薬 | 153,100円 | +3.2% | +4.5% | 3.40% | 17.59倍 | 0.67倍 |
|
医薬中堅。柱のぜんそく薬、呼吸器アレルギー薬は下期に比重。消化器領域育成。後発品も |
| 栄研化 | 246,000円 | +7.6% | +57.5% | 2.15% | 19.02倍 | 1.87倍 |
|
臨床検査薬大手。便潜血検査試薬（ＦＩＴ）はシェア７割。尿検査（ウロ）、遺伝子検査も育成 |
市場注目の銘柄
チャート関連のコラム
